C-Rad
30,5
SEK
+1,67 %
Mindre end 1K følgere
CRAD B
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
+1,67%
+5,9%
-5,13%
+1,67%
+0,49%
-21,19%
-39,48%
-6,15%
+134,89%
C-Rad operates in the medical technology industry and focuses on the development and manufacture of systems for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The business is present on a global level, with a main presence in Europe, North America and Asia. C-Rad was founded in 2004 and is headquartered in Uppsala, Sweden.
Læs mereMarkedsværdi
1,03 mia. SEK
Aktieomsætning
758,5 t SEK
Omsætning
469 mio.
EBIT %
14,93 %
P/E
18,26
Udbytteafkast, %
-
Finanskalender
7.5
2025
Delårsrapport Q1'25
8.5
2025
Generalforsamling '25
18.7
2025
Delårsrapport Q2'25
Alle
Selskabspræsentationer
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper

C-RAD, Audiocast with teleconference, Q1'25
C-RAD publishes its annual report for 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools

C-RAD, Audiocast with teleconference, Q4'24
C-RAD’s Year-End Report January-December 2024
Invitation to presentation of C-RAD’s year-end report and report for the fourth quarter 2024
